United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

Publisher Name :
Date: 15-Sep-2016
No. of pages: 100
Inquire Before Buying

Notes:

Sales, means the sales volume of Drugs for Respiratory Syncytial Virus (RSV)

Revenue, means the sales value of Drugs for Respiratory Syncytial Virus (RSV)

This report studies sales (consumption) of Drugs for Respiratory Syncytial Virus (RSV) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Ablynx

- ADMA Biologics

- Agilvax

- AlphaVax

- AmVac

- Aridis Pharmaceuticals

- Artificial Cell Technologies

- Astellas Pharma

- AstraZeneca

- Bavarian Nordic

- Biota Pharmaceuticals

- Celltrion

- Codagenix

- Crucell

- CureVac

- Emergent

- Roche

- GenVec

- Gilead Sciences

- GlaxoSmithKline

- Humabs BioMed

- Novavax

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Ribavirin

- Bronchodilator

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in each application, can be divided into

- Infants (Under 6 Month Old)

- Babies & Children

- Adults

United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

Table of Contents
United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021
1 Drugs for Respiratory Syncytial Virus (RSV) Overview
1.1 Product Overview and Scope of Drugs for Respiratory Syncytial Virus (RSV)
1.2 Classification of Drugs for Respiratory Syncytial Virus (RSV)
1.2.1 Ribavirin
1.2.2 Bronchodilator
1.2.3 Type III
1.3 Applications of Drugs for Respiratory Syncytial Virus (RSV)
1.3.1 Infants (Under 6 Month Old)
1.3.2 Babies & Children
1.3.3 Adults
1.4 USA Market Size (Value and Volume) of Drugs for Respiratory Syncytial Virus (RSV) (2011-2021)
1.4.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
1.4.2 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
1.4.3 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
2 USA Drugs for Respiratory Syncytial Virus (RSV) Competition by Manufacturers
2.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Share by Manufactures (2015 and 2016)
3 USA Drugs for Respiratory Syncytial Virus (RSV) (Volume and Value) by Type
3.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
3.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)
4 USA Drugs for Respiratory Syncytial Virus (RSV) (Volume) by Application
5 USA Drugs for Respiratory Syncytial Virus (RSV) Manufacturers Analysis
5.1 Ablynx
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology
5.1.2.1 Ribavirin
5.1.2.2 Bronchodilator
5.1.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
5.2 ADMA Biologics
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Ribavirin
5.2.2.2 Bronchodilator
5.2.3 Pharmaceuticals Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
5.3 Agilvax
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Agilvax Product Type and Technology
5.3.2.1 Ribavirin
5.3.2.2 Bronchodilator
5.3.3 Agilvax Sales, Revenue, Price of Agilvax (2015 and 2016)
5.4 AlphaVax
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 AstraZeneca Product Type and Technology
5.4.2.1 Ribavirin
5.4.2.2 Bronchodilator
5.4.3 AlphaVax Sales, Revenue, Price of AlphaVax (2015 and 2016)
5.5 AmVac
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 AmVac Product Type and Technology
5.5.2.1 Ribavirin
5.5.2.2 Bronchodilator
5.5.3 AmVac Sales, Revenue, Price of AmVac (2015 and 2016)
5.6 Aridis Pharmaceuticals
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 Aridis Pharmaceuticals Product Type and Technology
5.6.2.1 Ribavirin
5.6.2.2 Bronchodilator
5.6.3 Aridis Pharmaceuticals Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
5.7 Artificial Cell Technologies
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Artificial Cell Technologies Product Type and Technology
5.7.2.1 Ribavirin
5.7.2.2 Bronchodilator
5.7.3 Artificial Cell Technologies Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
5.8 Astellas Pharma
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Astellas Pharma Product Type and Technology
5.8.2.1 Ribavirin
5.8.2.2 Bronchodilator
5.8.3 Astellas Pharma Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
5.9 AstraZeneca
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 AstraZeneca Product Type and Technology
5.9.2.1 Ribavirin
5.9.2.2 Bronchodilator
5.9.3 AstraZeneca Sales, Revenue, Price of AstraZeneca (2015 and 2016)
5.10 Bavarian Nordic
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 Bavarian Nordic Product Type and Technology
5.10.2.1 Ribavirin
5.10.2.2 Bronchodilator
5.10.3 Bavarian Nordic Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
5.11 Biota Pharmaceuticals
5.12 Celltrion
5.13 Codagenix
5.14 Crucell
5.15 CureVac
5.16 Emergent
5.17 Roche
5.18 GenVec
5.19 Gilead Sciences
5.20 GlaxoSmithKline
5.21 Humabs BioMed
5.22 Novavax
6 Drugs for Respiratory Syncytial Virus (RSV) Technology and Development Trend
6.1 Drugs for Respiratory Syncytial Virus (RSV) Technology Analysis
6.2 Drugs for Respiratory Syncytial Virus (RSV) Technology Development Trend
7 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)
Table Classification of Drugs for Respiratory Syncytial Virus (RSV)
Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2015
Figure Ribavirin Picture
Figure Bronchodilator Picture
Table Applications of Drugs for Respiratory Syncytial Virus (RSV)
Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application in 2015
Figure Infants (Under 6 Month Old) Examples
Figure Babies & Children Examples
Figure Adults Examples
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales of Key Manufacturers (2015 and 2016)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Figure 2016 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue by Manufacturers (2015 and 2016)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table 2016 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Growth Rate by Type (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Application (2011-2021)
Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Application (2011-2021)
Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application (2011-2021)
Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2011-2021)
Table Ablynx Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)
Table ADMA Biologics Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)
Table Agilvax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)
Table AlphaVax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)
Table AmVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)
Table Aridis Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
Table Artificial Cell Technologies Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table AstraZeneca Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Bavarian Nordic Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)
Table Biota Pharmaceuticals Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Biota Pharmaceuticals (2015 and 2016)
Table Celltrion Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Celltrion (2015 and 2016)
Table Codagenix Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Codagenix (2015 and 2016)
Table Crucell Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Crucell (2015 and 2016)
Table CureVac Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of CureVac (2015 and 2016)
Table Emergent Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Emergent (2015 and 2016)
Table Roche Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Roche (2015 and 2016)
Table GenVec Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GenVec (2015 and 2016)
Table Gilead Sciences Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Gilead Sciences (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Humabs BioMed Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Humabs BioMed (2015 and 2016)
Table Novavax Basic Information List
Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Novavax (2015 and 2016)
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Global Botanical and Plant-Derived Drugs Sales Market Report 2016
    Published: 22-Sep-2016        Price: US 4000 Onwards        Pages: 123
    Notes: Sales, means the sales volume of Botanical and Plant-Derived Drugs Revenue, means the sales value of Botanical and Plant-Derived Drugs This report studies sales (consumption) of Botanical and Plant-Derived Drugs in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - ?Yunnan Baiyao......
  • Global Vitamin E Market Professional Survey Report 2016
    Published: 22-Sep-2016        Price: US 3500 Onwards        Pages: 112
    Notes: Production, means the output of Vitamin E Revenue, means the sales value of Vitamin E This report studies Vitamin E in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manuf......
  • United States Artificial Tears Market Report 2016
    Published: 22-Sep-2016        Price: US 3800 Onwards        Pages: 118
    Notes: Sales, means the sales volume of Artificial Tears Revenue, means the sales value of Artificial Tears This report studies sales (consumption) of Artificial Tears in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Johnson & Johnson (US) - Novartis International AG (Switzerland) - Abbott Medical Optics Inc. (US) - Bausch & Lomb Incorporated. (US) - Allerga......
  • United States Cylindrical Dental Implant Market Report 2016
    Published: 22-Sep-2016        Price: US 3800 Onwards        Pages: 122
    Notes: Sales, means the sales volume of Cylindrical Dental Implant Revenue, means the sales value of Cylindrical Dental Implant This report studies sales (consumption) of Cylindrical Dental Implant in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Sterngold Dental - Bredent medical - BioHorizons - DENTSPLY Implants - ADIN Dental Implant Systems - BHI Implants......
  • Global Animal Health Market Research Report 2016
    Published: 22-Sep-2016        Price: US 2900 Onwards        Pages: 102
    Notes: Production, means the output of Animal Health Revenue, means the sales value of Animal Health This report studies Animal Health in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Bayer - Merial - Virbac - Bupo Animal Health - Lion Bridge ......
  • Global Collagen Peptides Market Research Report 2016
    Published: 22-Sep-2016        Price: US 2900 Onwards        Pages: 114
    Notes: Production, means the output of Collagen Peptides Revenue, means the sales value of Collagen Peptides This report studies Collagen Peptides in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Rousselot(Peptan) - Gelita AG - Darling Ingredients - PB Gela......
  • Global Biosimilar Drug Sales Market Report 2016
    Published: 22-Sep-2016        Price: US 4000 Onwards        Pages: 129
    Notes: Sales, means the sales volume of Biosimilar Drug Revenue, means the sales value of Biosimilar Drug This report studies sales (consumption) of Biosimilar Drug in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Hospira - Sandoz - Teva Pharmaceutical Industries - P......
  • Global Biosimilar Monoclonal Antibodies Market Research Report 2016
    Published: 22-Sep-2016        Price: US 2900 Onwards        Pages: 106
    Notes: Production, means the output of Biosimilar Monoclonal Antibodies Revenue, means the sales value of Biosimilar Monoclonal Antibodies This report studies Biosimilar Monoclonal Antibodies in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Celltrion - Boehringer Ingelheim ......
  • Global Biosimilars Market Research Report 2016
    Published: 22-Sep-2016        Price: US 2900 Onwards        Pages: 116
    Notes: Production, means the output of Biosimilars Revenue, means the sales value of Biosimilars This report studies Biosimilars in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Roche - Amgen - AbbVie - Sanofi-Aventis - Johnson & Johnson - Pfizer ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs